Maxim Group Initiates Coverage On Intchains Gr With Buy Rating, Announces Price Target of $8
AIM ImmunoTech Enters $3M Equity Distribution Agreement With Maxim Group For "At the Market" Offering
Maxim Group Downgrades Galmed Pharmaceuticals to Hold
Surmodics Announced The Commercial Release Of The Pounce XL Thrombectomy System, The Latest In A Suite Of Pounce Thrombectomy Systems That Provide Rapid Endovascular Removal Of Acute Or Chronic Clot From Peripheral Arteries
Maxim Group Downgrades BioAffinity Technologies to Hold
WestPark Capital Initiates Coverage On Ideal Power With Hold Rating